Stock SRDX SURMODICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Surmodics, Inc.

Equities

SRDX

US8688731004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
26.17 USD 0.00% Intraday chart for Surmodics, Inc. -1.21% -28.01%
Feb. 06 Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating MT
Feb. 01 Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating MT

Evolution of the average Target Price on Surmodics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7b.YcxzIqIbtbn9qhu3slP7CmxcQ2XCPCSo8AV_xsR81II.Lq1eSON-h8-s2y3h5wXNaRUGCC-XdAnmwkQI_pZJhPUsmV5h71iGw8ThKw~40ec45e213fd487cc35f81aa55ec884b

Analyst Recommendations on Surmodics, Inc.

Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating MT
Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating MT
Barrington Ups Price Target on SurModics to $71 From $69 After Better-than-Expected Q4/23 Results, Keeps Outperform Rating MT
Barrington Research Raises PT on SurModics to $69 From $60, as Valuation Increases For SurVeil DCB Program After US FDA Approval; Maintains Outperform Rating MT
Needham Upgrades SurModics to Buy From Hold, Price Target is $36 MT
Needham Downgrades SurModics to Hold From Buy Given Uncertainty About SurVeil MT
Needham Adjusts Price Target on SurModics to $34 From $46, Maintains Buy Rating MT
Barrington Research Adjusts SurModics' Price Target to $60 From $61, Maintains Outperform Rating MT
Barrington Adjusts Price Target on SurModics to $61 From $70, Maintains Outperform Rating MT
Needham Adjusts SurModics' Price Target to $46 From $58; Buy Rating Kept MT
Needham Lowers Price Target for SurModics to $58 From $70, Maintains Buy Rating MT
Needham Adjusts SurModics PT to $70 From $76, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Boohoo, Boston Beer, Cisco Systems, Eversource, Frontline... Our Logo
SURMODICS : Needham & Co Adjusts SurModics PT to $76 From $68, Maintains Buy Rating MT
SURMODICS : Needham Adjusts SurModics' Price Target to $76 from $68, Keeps Buy Rating MT
SURMODICS : Needham Adjusts Price Target for SurModics to $68 From $61, Maintains Buy Rating MT
SURMODICS : Barrington Adjusts Price Target on SurModics to $70 From $63, Maintains Outperform Rating MT
SURMODICS : Barrington Research Adjusts SurModics' Price Target to $70 From $63, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.17 USD
Average target price
59 USD
Spread / Average Target
+125.45%
High Price Target
75 USD
Spread / Highest target
+186.59%
Low Price Target
44 USD
Spread / Lowest Target
+68.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Surmodics, Inc.

Barrington Research
Needham & Co.

Ratings for Surmodics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SRDX Stock
  4. Consensus Surmodics, Inc.